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Highlights 
 No reciprocal associations between maternal depression and infant sleep problems.  
 Antidepressant exposure not associated with increased infant sleep problems.   
 Maternal depression not associated with increased infant sleep problems.  
 Reciprocal longitudinal effects between maternal cognitions and infant waking.  
 Early maternal cognitions and infant waking predicted later night settling behaviours. 
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Abstract 
Background: Both perinatal depression and infant sleep problems are common concerns in 
many communities, with these problems often coinciding. Findings in this area conflict and 
much of the research relies on poor measures of sleep and/or depression. Adding to this 
complexity is the rise in antidepressant treatment for perinatal maternal depression and no 
previous study has examined the relationship between such exposure and infant sleep. 
Methods: This study draws on four waves of data (first and third trimesters, and six and 12 
months postpartum) from 264 women in the Mercy Pregnancy and Emotional Wellbeing 
Study, a prospective pregnancy cohort study of women recruited in first trimester in 
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Melbourne, Australia. Cross-lagged regression models were used to examine reciprocity of 
longitudinal effects between depressive symptoms and sleep.   
Results: Maternal antepartum depression and antidepressant use were not significant 
predictors of infant sleep problems. Likewise, infant sleep problems were not significant 
predictors of postpartum maternal depression. However, maternal cognitions about infant 
sleep, characterised by maternal expectations to immediately attend to their crying child, did 
demonstrate positive reciprocal effects with infant nocturnal waking between six and 12 
months postpartum. 
Limitations: Infant sleep outcomes were reported by the mother and the sample were 
predominantly Anglophone, restricting generalizability of the models to other cultures. 
Conclusions: Maternal depression and antidepressant use were not found to be significant 
factors in infant sleep problems and, likewise, infant sleep problems were not associated with 
maternal depression. However, postpartum maternal cognitions around six months 
postpartum regarding limit-setting at night may predict increases in later nocturnal infant 
signaling. 
Keywords 
Depression, Antidepressants, Infant Sleep 
 
 
 
 
 
Abbreviations 
AD: Antidepressant; BISQ: Brief Infant Sleep Questionnaire; CFI: Comparative Fit Index; 
EPDS: Edinburgh Postnatal Depression Scale; PIBBS: Parental Interactive Bedtime Behavior 
Scale; RMSEA: Root Mean Square Error of Approximation; SCID-IV: Structured Clinical 
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Interview for the DSM-IV; SRMR: Standardized Root Mean Square; SSRI: Selective 
Serotonin Reuptake Inhibitor   
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A range of factors including biological, socio-emotional, early parenting practices and 
cultural practices, and parental expectations can potentially influence the development of 
sleep patterns in infants. For many families there are challenges adjusting to infant sleep 
patterns and unsettled infants can adversely affect both parental and infant wellbeing. 
However, whether infant sleep patterns can influence the development of maternal depression 
remains unclear. In several studies, maternal depression has been implicated as an associated 
factor in infant sleep, but the true nature of the relationship between maternal mental health 
and infant sleep outcomes is yet to be fully understood.  
Studies relying only on maternal reports of depressive symptoms and of infant sleep 
outcomes demonstrate a significant association between an infant’s unsettled sleep and 
maternal depression. Indeed, unsettled infant sleep may predict maternal depression, 
suggesting that interventions aimed at improving infant sleep outcomes may improve 
maternal depression (Hiscock and Wake, 2001; Lam et al., 2003). However, research 
examining this relationship using observational methods has demonstrated the relationship to 
be more complex, with some maternal behaviors associated with depression affecting infant 
sleep behaviors such as night waking (Teti and Crosby, 2012). Adding to this complexity, 
there are key postpartum variables, such as breastfeeding, often unaccounted for in this area 
of research that can influence maternal and infant sleep patterns, and may affect depression 
symptoms (Dias and Figueiredo, 2015; Galbally et al., 2013). 
Furthermore, the infant sleep outcome can vary from night waking and signaling for 
the parent, parental settling behaviors, difficulties going to sleep and sleep location. Defining 
the sleep problem is crucial and varies in the research from parental perception of a problem, 
numbers of wakes in the night, to the time taken for an infant to fall sleep. For instance, night 
waking may be due to infant sleep problems, but equally, may be part of normal feeding 
behavior (Galbally et al., 2013). Making sense of current research findings is important given 
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potential implications for clinical translation and recommendations, depending on whether 
maternal factors or infant factors are stronger in this relationship and the nature of the infant 
sleep concern. Teti and Crosby have conceptualized the association between infant sleep and 
maternal depression as being either a maternal-driven model or an infant-driven model (Teti 
and Crosby, 2012).  
The maternal-driven model places the starting point at maternal depression, which 
then influences maternal cognitive response and actions around infant sleep and ultimately 
influencing infant sleep behaviors. This is supported by increased rates of depression in 
mother-infant pairs presenting to early parenting sleep and settling services (Fisher et al., 
2004). It is also supported by prospective research demonstrating maternal depression in 
pregnancy is associated with higher reported sleep difficulties in infants (Field et al., 2007; 
Nevarez et al., 2010). Likewise, a systematic review of interventions at improving infant 
sleep did not show a clear impact on infant night waking (signaling) or maternal depression 
(Douglas and Hill, 2013). A recent meta-analysis found an effect of infant sleep interventions 
on maternal depressive symptoms measured using the Edinburgh Postnatal Depression Scale 
(EPDS). Although, the authors comment that the two highest quality studies in their review 
did not report a significant association between infant sleep interventions and maternal mood 
(Kempler et al., 2016).  
An infant-driven model is conceptualized to start with an unsettled infant as a risk 
factor for the development of maternal depressive symptoms. A study that prospectively 
examined women who presented with an EPDS score less than 13 at one week postpartum 
and elevated EPDS scores at four and eight weeks postpartum, also reported fatigue and an 
unsettled infant with poor sleep (Dennis and Ross, 2005). A randomized control trial aimed at 
reducing depression and infant sleep problems demonstrated a small but significant reduction 
in depressive symptoms between four and six months postpartum for mothers in the 
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intervention arm. It should be noted, however, that for the intervention group, the average 
EPDS was 6.3 (SD = 4.4) at four months and 5.1 (SD = 4) at 6 months, suggesting that this 
sample was a low-risk sample for clinical depression (Hiscock et al., 2014). Few studies have 
used diagnostic measures for depression, with the majority relying on EPDS; as such, 
implications for depressive disorders cannot be drawn from this literature. Beyond the 
maternal- and infant-driven models, a range of environmental factors are often not examined 
in studies investigating infant sleep and maternal depression, but may equally influence both 
maternal depression and infant sleep. These factors include in-utero exposures including 
antidepressant medication and early parenting practices such as breastfeeding and infant sleep 
location. 
The use of antidepressant medication in pregnancy for women experiencing moderate 
to severe depression is rising and hence understanding any influence on infant sleep 
development is important. The most commonly prescribed antidepressant is a Selective 
Serotonergic Reuptake Inhibitor (SSRI), which has been shown to alter maternal sleep 
architecture, but as yet there is only limited exploration of the potential effect of fetal 
exposure on the development of infant sleep architecture (Jindal et al., 2003). One study of 
fetuses exposed to SSRIs throughout pregnancy reported disrupted development of quiet 
sleep in late pregnancy, but follow-up into the postpartum was not undertaken (Mulder et al., 
2011). Studies that examine neonatal behavior following exposure to SSRIs identify sleep 
changes as one of the most common symptoms (Galbally et al., 2017a; Zeskind and Stephens, 
2004). However, again, follow-up beyond the neonatal period is limited. These studies also 
rely on a script having been given or a hospital record yet many women discontinue treatment 
with antidepressants in pregnancy (Ververs et al., 2006). 
In this study, we built on existing research to examine the associations between 
maternal depression and antidepressant use, and infant sleep. First, we assessed the role of 
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8 
antidepressant exposure on infant sleep behaviors, including total nocturnal sleep time and 
nocturnal waking. As per previous findings, we predicted that the sleep behaviors of infants 
exposed to antidepressants would differ significantly compared to the sleep behaviors infants 
not exposed to antidepressants (hypothesis 1). For infant sleep behaviors that did vary, we 
predicted a dose effect of antidepressants, such that higher doses would be associated with 
stronger effects (hypothesis 2).  
Next, we assessed the role of clinically diagnosed maternal depressive disorder on 
infant sleep location, perception of sleep problems, support seeking for infant sleep problems, 
and use of parental bedtime settling strategies and behaviors. We predicted that mothers with 
a depressive disorder would be more likely to report different sleeping locations, and infant 
sleep perceptions, strategy use and behaviors compared to mothers not diagnosed with a 
depressive disorder (hypothesis 3). We also examined the role of a maternal depressive 
disorder on infant sleep behaviors at 6 and 12 months postpartum, testing the effect of 
breastfeeding as a moderator. Specifically, we predicted a significant interaction between 
maternal depressive disorder and breastfeeding on infant sleep behaviors (hypothesis 4).    
Finally, we extended the models for maternal depressed mood and infant sleep 
reported by Teti and Crosby (2012) by combining the mother- and infant-driven models, 
testing simultaneously the longitudinal effects of maternal depressive disorder and symptoms 
during pregnancy and the postpartum, and how these symptoms were associated with 
nocturnal infant waking in the postpartum, controlling for breastfeeding. Specifically, we 
predicted that the relations between postpartum maternal depressive symptoms and infant 
waking would be bidirectional, after controlling for antepartum depressive disorder and 
symptoms and breastfeeding in the postpartum (hypothesis 5). We also predict maternal 
bedtime settling behavior and maternal cognitions about infant sleep in the postpartum will 
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9 
be associated with maternal depressive symptoms and infant waking at 6 and 12 months 
postpartum (hypothesis 6).  
Method 
This is a prospective cohort study of 282 pregnant women recruited before the 20
th
 
week of pregnancy (Wave 1), and followed up during third trimester (Wave 2), birth of their 
child (Wave 3), and six months (Wave 4), 12 months (Wave 5) and 36 months postpartum 
(Wave 6). For this study, 264 women (Mage = 31.21, SDage = 4.69, range: 18 – 48 years old) 
were included using data from Waves 1, 2, 4 and 5. Women are missing if they had 
withdrawn prior to or after Wave 3 or if they were missing both postpartum waves. Study 
participants comprised three groups: women taking antidepressant medication in pregnancy 
(AD exposed; n = 47), non-medicated women who met diagnostic criteria for depression or 
dysthymia at recruitment (Depressed; n = 29), and control women (n = 189). Further details 
of the study are described in the published study protocol (Galbally et al., 2017b). Mercy 
Health Human Research Ethics Committee approved this study and all participants provided 
informed, written consent. 
Measures 
Mother reported whether they had ceased breastfeeding at 6 and 12 months 
postpartum (0 = ceased breastfeeding, 1 = breastfeeding), and whether their infant slept in 
the same room (0 = own room, 1 = parents’ room) and on the same surface (0 = own surface, 
1 = parents’ surface).  
A diagnostic measure was undertaken at recruitment: the Structured Clinical 
Interview for DSM-IV (SCID-IV) Mood disorders schedule (First et al., 1997). In addition, 
the Edinburgh Postnatal Depression Scale (EPDS) was administered at Waves 1, 2, 4 and 5 
(Cox et al., 1987). The scale has been validated for use with Australian women during the 
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10 
perinatal period, where sensitivity and specificity for cut-off scores of 12.5 and 13.5 were 100 
and 95.7%, respectively (Boyce et al., 1993).  
Antidepressant type, usage, dosage and timing during pregnancy was self-reported by 
women, as well as obtained from hospital records at delivery. As the majority of participants 
were on sertraline, all doses of antidepressants were converted to a sertraline-equivalent 
dosage using a conversion chart (Procyshyn et al., 2015). Participant-reported antidepressant 
dose during the first trimester is used for this analysis. 
Maternal blood and umbilical cord blood were also collected within 30 minutes of 
delivery and assayed for drug levels. Blood was centrifuged and the plasma stored at -80°C 
within one hour of collection. All samples were analyzed with liquid chromatography with 
mass spectrometry or tandem mass spectrometry, with methods described previously 
(Andreassen et al., 2015; Reis et al., 2009). The assay levels for each antidepressant type 
were standardized by relating the concentrations measured to the middle of the therapeutic 
range for the same drug (Hiemke et al., 2011) so that concentration levels were comparable 
across the variety of applied antidepressants.  
The Brief Infant Sleep Questionnaire (BISQ), a 13-item parent report measure, 
administered at both postpartum waves to assess duration and quality of infant sleep during 
the previous week. Individual items measure the following: nocturnal and diurnal sleep 
duration (hours), nocturnal infant waking (referred to as infant signaling) (frequency), and 
duration of nocturnal wakefulness duration and nocturnal sleep-onset (minutes). Also 
measured is the degree to which the mother believes the infant’s sleeping is a problem (A 
very serious problem, A small problem, and Not a problem at all) (Sadeh, 2004).  
The Parental Interactive Bedtime Behavior Scale (PIBBS) is a 17-item scale to assess 
a range of parental behaviors used to settle infants to sleep and was administered at 12 
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months postpartum (Morrell and Cortina‐Borja, 2002). Domains of settling behavior include 
physical comforting, encouraging autonomy, movement, passive physical comforting, and 
social comforting. Each item is measured using a 5-point Likert scale (0 = Never, 4 = Very 
Often). We used a total score, computed to represent the percentage (ranging 0 to 100%) of 
time mothers report using these strategies to settle their child at bedtime. The subscales have 
been demonstrated as reliable and valid in several samples (Morrell and Cortina‐Borja, 2002). 
We used three items from the Setting Limits subscale of the Maternal Cognitions 
about Infant Sleep Questionnaire to operationalize mothers’ cognitions about their child’s 
sleep described as maternal sleep cognitions within this study (Morrell, 1999). Each item is 
measured using a 6-point Likert scale (0 = Strongly agree, 5 = Strongly disagree). The items 
were “It is alright to let my child cry at night”, “My child will feel abandoned if I don’t 
respond immediately to his/her cries at night” and “I should respond straightaway when my 
child wakes crying at night”. Prior to averaging, the second and third items were reverse-
coded, which resulted in higher scores indicating mothers’ who had trouble resisting their 
children’s crying at night. In our data, these items demonstrated good internal consistency at 
both six (α = .81) and 12 months (α = .76) postpartum.  
Data Analyses 
We used SPSS version 24 (IBM Corp., 2016) to conduct analyses for hypotheses 1 to 
4. To address hypothesis 1, we presented infant sleep outcomes (BISQ) at 6 and 12 months 
post-partum for women taking antidepressants and women not antidepressants, accompanied 
by inferential tests (F and χ
2 
tests) to determine the significance of group differences. When 
variance between groups differed significantly, we presented the result of the more robust 
Welch F test. To address hypothesis 2, we presented Spearman’s correlations to test for 
associations between antidepressant dose and sleep outcomes that differ between AD exposed 
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versus not exposed. These associations were only tested in the subset of women exposed to 
antidepressants and provided maternal and cord blood following labor (n = 42).  
To address hypothesis 3, we presented infant sleep location, and maternal perceptions 
and behaviors relating to infant sleep for depressed and non-depressed women, comparing 
differences inferentially using a series of bivariate logistic regressions. For hypothesis 4, we 
conducted a series of factorial (2x2) analysis of variance tests, using the BISQ outcomes for 
both postpartum waves, testing the interaction between depressive disorder groups and 
breastfeeding.  
To address hypothesis 5 that postnatal maternal depression and infant waking were 
bidirectional associations even when controlling for antenatal depression and breastfeeding 
and hypothesis 6 that postpartum depression and infant sleep will be associated with maternal 
cognitions and behaviours we used Mplus version 8 (Muthén and Muthén, 1998-2012) to 
analyse these models. The conceptual overall model, including nested models, to be tested are 
presented in Figure 1. Figure 2 presents the best fitting model following model testing 
analyses. We describe the steps to reach this below.  
To undertake this analysis for hypothesis 5 and 6 we first conducted a series of nested 
cross-lagged panel models, using repeat measures at first and third trimester, and six and 12 
months postpartum. As data were multivariate non-normal, we used maximum likelihood 
with robust standard errors (MLR) to estimate the models, with data missing at random 
estimated using full-information maximum-likelihood. We then followed the cross-lagged 
panel modelling process described by Geiser (2013). Progressively less constrained models 
were compared using Satorra’s (Bryant and Satorra, 2012) scaled Chi-square difference tests 
and the Akaike Information Criteria (AIC) value. The best fitting model was presented in 
Figure 2 to address study hypotheses 5 and 6. We considered Comparative Fit Index (CFI) ≥ 
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.95, Root Mean Square Error of Approximation (RMSEA) ≤ .05, and Standardized Root 
Mean Square (SRMR) ≤ .08 to indicate a model that fit the data well Hu and Bentler (1999).  
The nested models presented conceptually in Figure 1 were tested and are described 
below. The best fitting model from this process is presented in Figure 2. Model 1 is the 
baseline model comprising paths a through e, inclusive; this model formed the basis of 
comparison for subsequent less constrained models. In this model, all first- and second-order 
autoregressive paths for depressive symptoms scores and first-order autoregressive paths for 
cognitions about infant sleep and infant signaling were estimated (a paths). Pathways 
between both antepartum depression and depressive symptoms at third trimester with six-
month postpartum infant signaling and cognitions about infant sleep were estimated (b paths). 
Cross-sectional pathways between breastfeeding and infant signaling at six and 12 months 
postpartum were also estimated (c paths). Finally, covariances were estimated between cross-
sectional measurements to account for contemporaneous associations. 
<Figure 1> 
In model 2, pathways were estimated originating from depressive symptoms at 6-
months to cognitions about infant sleep, bedtime settling behaviors and infant signaling all at 
12 months (f paths). In model 3, pathways were estimated originating from infant signaling at 
6-months to depressive symptoms, bedtime settling behaviors and cognitions about infant 
sleep all at 12 months (g paths). In model 4, pathways were estimated originating from 
cognitions about infant sleep at 6-months to depressive symptoms, bedtime settling behaviors 
and infant signaling all at 12 months (h paths). In the final model (Model 5), all cross-lagged 
pathways were included (paths f, g and h) to estimate the full cross-lagged model.  
Results 
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As predicted in our first hypothesis, we expected antidepressant exposure to influence 
sleep outcomes (Table 1). Infants differed only at six months postpartum in the average 
number of hours they were sleeping at night, such that infants with AD exposure slept for a 
significantly shorter period between 7pm and 7am. All other comparisons between the groups 
were not significant (p > .01). 
<Table 1> 
None of the correlations for infant nocturnal sleep duration with sertraline-equivalent 
dose, and maternal and cord plasma were significantly different from zero (Supplementary 
Table 1). This suggests there is no evidence of a dosage effect of antidepressant exposure on 
duration of sleep at night in infants at both 6 and 12 months post-partum. 
Regarding maternal depression and infant sleep, depressed women were nearly three 
times more likely to be sleeping on the same surface as their infant at six months, compared 
to control women (Table 2). At 12 months postpartum, depressed women were twice as likely 
to be sleeping in the same room as their child, compared to healthy women. The two groups 
did not differ on any of the other measures, including bedtime settling behaviors. 
<Table 2> 
For the factorial ANOVAs, none of the main effects for the depression groups were 
significant and none of the interactions between breastfeeding and depression for infant sleep 
outcomes were significant. However, mothers who were still breastfeeding at six months 
reported significantly more nocturnal infant signaling at six months (M = 2.28, SD = 1.70) 
compared to those mothers who had stopped breastfeeding (M = 1.18, SD = 1.01), F(1, 213) 
= 17.29, p < .001. This pattern was the same at 12 months, with mothers still breastfeeding 
reporting significantly more infant signaling at night (M = 1.85, SD = 1.50) compared to 
those mothers who had stopped breastfeeding (M = 1.12, SD = 1.02), F(1, 175) = 14.88, p < 
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.001. None of the other infant sleep outcomes (BISQ) differed between the breastfeeding 
groups at either wave.  
Table 3 displays zero-order bivariate correlation coefficients and descriptive statistics 
for all variables included in the modelling. Table 4 displays the results of the nested cross-
lagged model comparison testing.  
<Table 3> 
<Table 4> 
Model 1 was an adequate fit to the data (CFI = .94, RMSEA = .06 [.04, .08], SRMR = 
.08). Adding the crossed effects of depressive symptoms at six months postpartum to infant 
signaling, bedtime settling behavior and cognitions about infant sleep all at 12 months (i.e., 
Model 2), did not improve upon the fit of Model 1. This suggests that early postpartum 
depressive symptoms are not predictive of later postpartum infant nocturnal signaling. 
Adding the crossed effects of infant signaling at six months postpartum to depressive 
symptoms, bedtime settling behavior and maternal limit setting cognitions about infant sleep 
all at 12 months postpartum (i.e., Model 3), significantly improved the fit of Model 1. So too, 
the addition of pathways between cognitions about infant sleep at six months and depressive 
symptoms, bedtime settling behavior and infant signaling (i.e., Model 4), improved the fit of 
Model 1. Given Model 2 did not improve on the fit of Model 1, the f paths in Figure 1 
(online) were not included in the final cross-lagged model (Model 5). Model 5 was a better fit 
compared to all other models (CFI = .98, RMSEA = .04 [.00, .06], SRMR = .05), suggesting 
that over and above the effects of antepartum depression, depressive symptoms, breastfeeding 
and autoregressive paths, early postpartum infant signaling and cognitions about infant sleep 
are significantly associated with later postpartum infant signaling, cognitions about infant 
sleep and bedtime settling behaviors.  
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
 
16 
Figure 2 displays significant path coefficients for Model 5. Antepartum depressive 
symptoms were only significantly associated with postpartum depressive symptoms via first- 
and second-order autoregressive paths. Antepartum depressive disorder measured on the 
SCID-IV did not predict any of the postpartum measures, including depressive symptoms. At 
six months postpartum, breastfeeding was associated with significantly more infant signaling; 
however, by 12 months, the cross-sectional association was not significant. There were no 
significant bidirectional associations between depressive symptoms and infant signaling; 
therefore, we reject hypothesis 5. Only one non-autoregressive path was a significant 
predictor of depressive symptoms: higher maternal sleep cognitions regarding setting infant 
sleep limits at six months were associated with higher depressive symptoms at 12 months.  
<Figure 2> 
Although there were no significant cross-lag paths between postpartum depressive 
symptoms and infant signaling in the postpartum, there were significant cross-lag paths 
between maternal cognitions about infant sleep and infant signaling. Higher maternal infant 
sleep cognitions at six months predicted more infant signaling at 12 months, and more infant 
signaling at six months predicted higher maternal sleep cognitions at 12 months. Comparison 
of the standardized coefficients suggests that the earlier effect of sleep cognitions on later 
signaling (β = .18) is slightly stronger than the earlier effect of infant signaling on later 
maternal sleep cognitions (β = .16). More infant signaling and higher sleep cognitions at six 
months were both significantly predictive of mothers spending more time engaged in bedtime 
infant sleep behaviors at 12 months. As the cross-lagged paths for depressive symptoms were 
not included in the final model and six month infant signaling did not directly predict 
depressive symptoms, the two-wave mediation analyses were not undertaken. Therefore, 
there is no support for hypothesis 6, which predicted mediation between infant signaling and 
depressive symptoms through maternal sleep cognitions and bedtime settling behaviors.   
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Discussion 
Our findings do not support a relationship between either earlier maternal depression 
predicting later infant sleep outcomes, or earlier increased infant nocturnal signaling 
predicting later depression. Maternal cognitions regarding setting limits for infant sleep, such 
as concern their baby will feel abandoned if not immediately responded to at night, did 
predict depressive symptoms at 12 months of age and these maternal cognitions also 
predicted increased nocturnal signaling at 12 months and increased active maternal bedtime 
comforting behaviors. Despite the lack of support from the cross-lagged paths between 
maternal depression and infant signaling, there was a significant positive contemporaneous 
association between maternal depressive symptoms and infant signaling at six months.  
Of note, there was no association with fetal antidepressant exposure and sleep 
development in infants and this study utilized robust measures of exposure ranging from 
prospective self-report and hospital records through to both maternal and cord blood levels to 
increase certainty of exposure (Galbally et al., 2017a). Similarly, depression was not 
associated with perceived infant sleep problems or settling behaviors using a diagnostic 
measure of depression in pregnancy or self-report symptoms across the perinatal period.  
However, depression was associated with an increase in likelihood that an infant would share 
a bed surface six months and a room at 12 months postpartum. Breastfeeding was associated 
with increased infant night signaling at six and 12 months and women who were on 
antidepressant medication had infants who slept less overnight, and as previously, reported 
also breastfed more frequently, which persisted to 12 months of age (Galbally et al., 2018, in-
press). 
Infant sleep development begins in utero and continues across the neonatal, infancy 
and early childhood periods. Sleep gradually decreases in quantity but increases in 
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consolidated periods following a rhythm across day and night, and sleeping through the night 
is an important milestone in developmental maturity (Mirmiran et al., 2003). Research into 
sleep development suggest a range of important biological factors, which include gestation at 
birth, demand breastfeeding where maternal melatonin contained in milk will match the time 
of day for the infant, light/dark exposure, and maternal sleep regulation (Mirmiran et al., 
2003). Beyond these biological factors is also the environmental context that infant sleep 
development occurs within including parenting practices and expectations around infant sleep 
that can vary across individuals, families and cultures. Therefore, understanding infant sleep 
problems needs to be in the context of an understanding of the developmental and changing 
nature of infant sleep over the first year of life.  
Research into understanding the relationship between infant sleep and maternal 
depression has been hampered by measurement and methodological concerns. These include 
the definition of infant sleep problems as well as the measurement of maternal depression. 
For instance, within a normal sleep cycle for infants, there is brief waking; however, reports 
of infant signaling in the night suggests the infant wakes and is unable to re-settle and signals 
to the parent, but this is often defined in studies without distinguishing if a baby is waking to 
breastfeed or is truly unsettled overnight (Keener et al., 1988). Given the majority of 
breastfed babies will continue to feed regularly overnight to at least 6 months of age and may 
need to signal to ensure they are fed, the reason for waking is an important consideration 
when defining a sleep problem (Galbally et al., 2013; Hörnell et al., 1999). Likewise, settling 
to sleep at night is influenced by parenting sleep practices, sleep location and may reflect 
aspects of the mother-infant relationship (Beijers et al., 2011; Sadeh et al., 2016; Teti et al., 
2010). Furthermore, an important aspect of understanding the quality of early mother-infant 
relationship is the role of maternal depression given the well-characterized effect this may 
have on the mother-infant relationship. Yet typically, when maternal depression is included in 
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studies of infant sleep, measurement has relied on screening self-report measures in low-risk 
populations.  
While poor infant sleep is associated with poorer child developmental outcomes, 
research that has focused on breastfeeding has not found an association with adverse child 
development outcomes (Quinn et al., 2001; Sadeh et al., 2015). It may be that signaling to a 
caregiver overnight when it does not impact on sleep quantity may not be detrimental for 
developmental outcomes, but represent a relational response to nighttime parenting practices. 
While we found breastfeeding was associated with increased night signaling previously, we 
have not found an increase in depression in breastfeeding women in this sample (Galbally et 
al., 2018, in-press). Furthermore, a focus on interventions aimed at extinguishing infant 
night-time signaling may have an unwanted effect of reducing the public health goal of 
improving breastfeeding duration. Therefore, studies that examine depression and infant sleep 
need to include feeding method and find methods that distinguish infant night waking for 
feeding from true infant sleep problems.  
Our findings were drawn from Anglophone populations and as such, it was not 
possible to explore the cultural diversity of early parenting practices around infant sleep, 
which may also be relevant for maternal depression. However, there is evidence that in 
cultures where infant sleep practices are significantly different, for instance in Japan where 
there are higher rates of bed sharing, both night waking and associated signaling through cry 
is common and it is unclear if this may relate to maternal depression (Fukumizu et al., 2005; 
Latz et al., 1999). Future research would benefit from replication in other cultural contexts 
would be useful to understand if infant sleep practices influence this model. A further 
limitation was the reliance on maternal report for infant sleep. This study would be enhanced 
by the use of objective sleep measures for both mother and infant.  
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The strengths of this study include the careful characterization of maternal depression 
across pregnancy and the postpartum, and including data on treatment of depression with 
antidepressant medication. Infant sleep outcomes and associated parenting behaviors around 
infant sleep were also operationalized using several measures, including infant behavior, 
parenting settling techniques and maternal cognitions about sleep. Breastfeeding, a common 
confounding variable when considering infant sleep, was also controlled for in our models. 
This allowed us to untangle the presence of additive effects of both maternal depressive 
symptoms and cognitions on infant signaling, beyond normal waking for feeding.  
Future research is required to understand how maternal mental health in pregnancy 
may also influence these signals such as through maternal cortisol and melatonin in the 
development of infant sleep. This could be through fetal programming mechanisms such as 
explored in other areas of research on maternal depression and child outcomes (Gentile, 
2017; Lewis et al., 2014). Equally though, studies need to examine mental health and key 
postpartum variables such as the social, cultural and psychological factors including 
breastfeeding, parenting strategies and sleep practices, which may also influence infant sleep. 
It is only through this level of sophisticated research that we will understand the important 
relationship between maternal depression and infant sleep and most important translate this 
knowledge into evidence based guidance, recommendations and interventions for women and 
children. Overall, our findings suggest a focus on maternal treatment is important for 
understanding infant night waking and further research could examine whether effective 
treatment of depression assists infant sleep behaviors and development. 
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Figure 1. Full cross-lagged panel model. 
 
Figure 2. Model 5 cross-lag panel model results (N = 254). Greyed-out, dashed lines denote 
non-significant paths. Percentages represent explained variance (i.e., R
2
). *p < .05 **p < .01 
***p < .001. 
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Table 1. Mean (SD) differences for infant sleep outcomes (BISQ) at 6 and 12 months postpartum 
between mothers not exposed to antidepressants and mothers exposed to antidepressants (N = 264). 
  
Not Exposed 
to AD 
(n = 217) 
Exposed to 
AD  
(n = 47) F p 
BISQ at 6 Months Postpartum 
  
 
 Nocturnal sleep duration (hours) 10.08 (1.34) 9.52 (1.64) 5.43 .021 
Daytime sleep duration (hours) 3.60 (1.51) 3.82 (1.36) 0.72 .397 
Nocturnal infant signalling (frequency) 1.98 (1.44) 2.44 (2.17) 1.67
†
 .203 
Duration of night wakefulness (minutes) 38.04 (43.77) 52.61 (62.83) 3.11 .079 
Nocturnal sleep onset (minutes) 28.14 (29.49) 31.10 (30.93) 0.34 .560 
BISQ at 12 Months Postpartum 
    
Nocturnal sleep duration (hours) 10.50 (1.24) 10.16 (1.74) 2.05 .154 
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Daytime sleep duration (hours) 2.51 (1.23) 2.28 (.85) 1.14 .286 
Nocturnal infant signalling (frequency) 1.46 (1.45) 1.50 (.96) 0.05
†
 .822 
Duration of night wakefulness (minutes) 33.16 (78.36) 31.78 (35.93) 0.01 .922 
Nocturnal sleep onset (minutes) 21.39 (16.52) 25.62 (25.49) 0.86
†
 .359 
† 
Welch F Test due to significant heterogeneity of group variances. 
 
Table 2. Infant sleep outcomes (BISQ; n, %) and bedtime settling behaviours (PIBBS; M, 
SD) between depressed and non-depressed mothers (diagnosed using the SCID-IV; N = 264). 
  
Not Depressed  
(n = 206) 
Depressed  
(n = 58) 
   n (%) n (%) OR [95% CIs] 
Infant Sleep Arrangements 
  
 
Sharing surface at 6 months 20 (10.8) 11 (21.6) 2.83 [1.01, 5.14] 
Sharing surface at 12 months 44 (23.7) 12 (23.5) 1.72 [.77, 3.82] 
Sleeping in parents' room at 6 
months 
64 (34.4) 23 (45.1) 1.57 [.84, 2.94] 
Sleeping in parents' room at 12 
months 
43 (25.9) 17 (42.5) 2.11 [1.03, 4.33] 
Perceived Infant Sleep Problem at 6 
months 
86 (45.7) 22 (42.3) .87 [.47, 1.62] 
Perceived Infant Sleep Problem at 12 
months 
88 (50.0)  20 (47.6) .91 [.46, 1.78] 
Sought Help for Infant Sleep Problem at 
12 months (%) 
54 (30.7) 13 (31.0) 1.01 [.49, 2.10] 
Use Bedtime Sleep Strategy at 12 72 (41.1) 18 (43.9) 1.12 [.56, 2.22] 
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months (%) 
  M (SD) M (SD) F (p-value) 
PIBBS Total at 12 Months 30.05 (8.87) 28.57 (7.50) 0.349 
Active Physical Comforting 20.86 (14.34) 20.94 (13.50) 0.974 
Encourage Autonomy 18.91 (14.11) 17.31 (12.88) 0.517 
Settle by Movement 11.56 (17.10) 8.13 (14.86) 0.243 
Passive Physical Comforting 14.97 (17.53) 9.94 (15.22) 0.099 
Social Comforting 22.11 (16.28) 23.28 (16.81) 0.684 
Note. BISQ, Brief Infant Sleep Questionnaire; PIBBS, Parent Interactive Bedtime Behaviours Scale; 
SCID-IV; Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental 
Disorders, Fourth Edition. 
 
Table 3. Descriptive statistics and zero-order bivariate correlations between all variables 
included in the cross-lagged models (N = 264) 
    1 2 3 4 5 6 7 8 9 10 11 
1
2 
1. SCID-IV 
Depression
a
 
(
W
1) - 
           
2. Depressive 
Symptoms 
(
W
1) 
.39
**
* - 
          
3. Depressive 
Symptoms 
(
W
2) 
.34
**
* 
.67
**
* - 
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4. Depressive 
Symptoms 
(
W
4) 
.28
**
* 
.50
**
* 
.56
**
* - 
        
5. Depressive 
Symptoms 
(
W
5) 
.30
**
* 
.53
**
* 
.59
**
* 
.68
**
* - 
       
6. Cognitive 
Limit-setting 
(
W
4) 
-
.09 
-
.08 
-
.07 .01 
-
.17
* - 
      
7. Cognitive 
Limit-setting 
(
W
5) 
-
.11 
-
.12 
-
.10 
-
.05 
-
.17
* 
.68
*** - 
     8. Bedtime 
Settling 
Behaviours 
(
W
5) 
-
.04 .06 .03 .11 
.15
* 
-
.23
** 
-
.19
** - 
    9. Nocturnal 
Infant 
Signalling  
(
W
4) .05 .00 .04 
.17
* .13 
-
.19
** 
-
.29
*** .22** - 
   10. Nocturnal 
Infant 
Signalling  
(
W
5) 
-
.07 .03 
-
.04 
.15
* 
.17
* 
-
.30
*** 
-
.32
*** 
.31**
* 
.60
**
* - 
  
11. 
Breastfeeding
a
 
(
W
4) 
-
.05 
-
.11 
-
.14
* 
-
.03 
-
.19
** -.02 -.08 .19* 
.24
**
* 
.1
3 - 
 12. ( - .03 0.0 .02 - -.06 - .21** .27 .2 .50 - 
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Breastfeeding
a
 W
5) 
.10 1 .04 .16
* 
**
* 
5*
* 
**
* 
Mean 
 
.22 
6.5
5 
6.3
5 
5.9
5 
6.4
6 
3.0
0 
3.3
9 29.91 
2.0
4 
1.
41 .76 
.
3
7 
Standard 
Deviation 
 
.41 
4.7
4 
4.5
3 
4.5
5 
4.8
9 
1.2
4 
1.2
4 8.65 
1.6
0 
1.
29 .43 
.
4
8 
Range 
 
0-1 
0-
27 
0-
25 
0-
24 
0-
25 1-6 1-6 
13.33-
65.83 
0-
10 
0-
7 0-1 
0
-
1 
b
Correlations with SCID-IV Depression and Breastfeeding Cessation are point-biserial 
coefficients. 
*p < .05 **p < .01 ***p < .001. 
 
Table 4. Comparison of nested cross-lagged models 
Model χ2 d.f. 
Satorra-
Bentler 
Scaled 
Correction 
Factor 
Model 
Comparison 
Satorra-
Bentler 
Scaled 
Δχ2 Δd.f. AIC 
M1: No Cross-lagged 
Effects 
75.07 37 1.03 
   
8340.84 
M2:Depressive 
symptoms effects 
72.12 34 1.02 M1 vs. M2 2.58 3 8343.19 
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M3: Infant Signalling 
Effects 
57.94 34 1.03 M1 vs. M3 16.63** 3 8329.52 
M4: Infant Sleep 
Cognition Effects 
54.85 34 1.03 M1 vs. M4 19.63*** 3 8325.83 
M5: Full Cross-lagged 
Model 
41.39 31 1.03 M1 vs. M5 32.74*** 3 8318.19 
 
   
M2 vs. M5 33.60*** 3 
 
 
   
M3 vs. M5 16.08** 3 
 
 
   
M4 vs. M5 13.08** 3 
 
**p < .01 ***p < .001        
 
